Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 853086, 13 pages
http://dx.doi.org/10.1155/2014/853086
Research Article

A RXR Ligand 6-OH-11-O-Hydroxyphenanthrene with Antitumour Properties Enhances (−)-Epigallocatechin-3-gallate Activity in Three Human Breast Carcinoma Cell Lines

1Department of Pharmacology and Biotechnology (FaBiT), University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy
2Department of Specialistic, Diagnostic and Experimental Medicine (DIMES), University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy
3Department of Specialistic, Diagnostic and Experimental Medicine (DIMES), University of Bologna, Via Massarenti 9, 40138 Bologna, Italy
4Department of Biological, Geological, and Environmental Sciences, (BiGea), University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy

Received 10 February 2014; Accepted 5 May 2014; Published 11 June 2014

Academic Editor: Beatrice Charreau

Copyright © 2014 Fulvia Farabegoli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Supplementary Figure 1: Cytotoxicity assay of EGCG and IIF individual treatments on MCF-7, MCF-7TAM and MDA-MB-231 cells.

Supplementary Figure 2: Apoptosis in PHA stimulated Peripheral Blood Lymphocytes treated with EGCG and IIF.

Supplementary Figure 3: LR67 Immunostaining. LR67 expression was clearly visible in the cytoplasm and plasma membrane of CTRL and treated cells (a-f).

Supplementary Figure 4: Foxo3a immunostaining.

Supplementary Table 1: EGCG and IIF interactions.

  1. Supplementary Materials